SK282744B6 - Kapsula opuzdrujúca bunku produkujúcu cytochróm P450, farmaceutický prostriedok a súprava s jej obsahom, a jej použitie - Google Patents
Kapsula opuzdrujúca bunku produkujúcu cytochróm P450, farmaceutický prostriedok a súprava s jej obsahom, a jej použitie Download PDFInfo
- Publication number
- SK282744B6 SK282744B6 SK1323-98A SK132398A SK282744B6 SK 282744 B6 SK282744 B6 SK 282744B6 SK 132398 A SK132398 A SK 132398A SK 282744 B6 SK282744 B6 SK 282744B6
- Authority
- SK
- Slovakia
- Prior art keywords
- cytochrome
- cells
- prodrug
- capsule
- vector
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
- C12N9/0079—Steroid 11 beta monooxygenase (P-450 protein)(1.14.15.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10041—Use of virus, viral particle or viral elements as a vector
- C12N2740/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK35296 | 1996-03-27 | ||
PCT/EP1997/001585 WO1997035994A2 (fr) | 1996-03-27 | 1997-03-27 | Vecteurs retroviraux transducteurs du cytochrome p450 |
Publications (2)
Publication Number | Publication Date |
---|---|
SK132398A3 SK132398A3 (en) | 1999-04-13 |
SK282744B6 true SK282744B6 (sk) | 2002-12-03 |
Family
ID=8092560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1323-98A SK282744B6 (sk) | 1996-03-27 | 1997-03-27 | Kapsula opuzdrujúca bunku produkujúcu cytochróm P450, farmaceutický prostriedok a súprava s jej obsahom, a jej použitie |
Country Status (19)
Country | Link |
---|---|
US (1) | US6893634B1 (fr) |
EP (1) | EP0892852B1 (fr) |
JP (1) | JP4229982B2 (fr) |
AT (1) | ATE309383T1 (fr) |
AU (1) | AU713382B2 (fr) |
CA (1) | CA2250173A1 (fr) |
CZ (1) | CZ288074B6 (fr) |
DE (1) | DE69730595D1 (fr) |
DK (1) | DK0892852T3 (fr) |
ES (1) | ES2253775T3 (fr) |
HU (1) | HU221349B1 (fr) |
IL (1) | IL125795A0 (fr) |
NO (1) | NO325392B1 (fr) |
NZ (1) | NZ331765A (fr) |
PL (1) | PL188323B1 (fr) |
RU (2) | RU2185821C2 (fr) |
SI (1) | SI0892852T1 (fr) |
SK (1) | SK282744B6 (fr) |
WO (1) | WO1997035994A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT835137E (pt) | 1995-06-27 | 2004-12-31 | Gsf Forschungszentrum Umwelt U | Celulas encapsuladas produtoras de particulas virais |
DE69730595D1 (de) | 1996-03-27 | 2004-10-14 | Bavarian Nordic As Kvistgaard | Verkapselte zellen expremierend cytochrome p450 für die aktivierung einer medikamentenvorstufe |
US6540995B1 (en) | 1996-03-27 | 2003-04-01 | Bavarian Nordic Research Institute Gmbh | Encapsulated cells producing cytochrome P450 |
JP2002526510A (ja) * | 1998-09-21 | 2002-08-20 | トランジェーヌ、ソシエテ、アノニム | 薬剤またはプロドラッグを必要とする患者の予備治療のための医薬組成物 |
GB0400443D0 (en) | 2004-01-09 | 2004-02-11 | Oxford Biomedica Ltd | Cascade |
US7091040B1 (en) * | 1999-01-04 | 2006-08-15 | Innovata Plc | P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT) |
GB9900009D0 (en) * | 1999-01-04 | 1999-02-24 | Ml Lab Plc | Gene therapy |
GB0010105D0 (en) * | 2000-04-26 | 2000-06-14 | Ml Lab Plc | Cell ablation |
AU2002336162A1 (en) * | 2001-09-21 | 2003-04-01 | Oxford Biomedica (Uk) Limited | Pseudotyped retroviral vector system |
GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
MX2015006813A (es) | 2015-05-29 | 2016-11-28 | Univ Nac Autónoma De México | Nanoparticulas biocataliticas cyp-p22 con actividad citocromo p450 para la activacion de profarmacos. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0371119B1 (fr) | 1988-05-17 | 1996-09-04 | Sloan-Kettering Institute For Cancer Research | Vecteur retroviral |
WO1994029437A1 (fr) | 1993-06-07 | 1994-12-22 | University Of Medicine & Dentistry Of New Jersey | Vecteurs retroviraux exempts de region u3, exempts de recombinaison, a auto-inactivation, hautement efficaces |
US5688773A (en) * | 1994-08-17 | 1997-11-18 | The General Hospital Corporation | Method of selectively destroying neoplastic cells |
CA2198210C (fr) | 1994-09-02 | 2006-07-11 | Walter Henry Gunzburg | Vecteurs retroviraux utiles comme vehicules de transfert genique pour therapie genique |
PT835137E (pt) | 1995-06-27 | 2004-12-31 | Gsf Forschungszentrum Umwelt U | Celulas encapsuladas produtoras de particulas virais |
AU6987696A (en) * | 1995-09-06 | 1997-03-27 | Bavarian Nordic Research Institute A/S | The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
DE69730595D1 (de) | 1996-03-27 | 2004-10-14 | Bavarian Nordic As Kvistgaard | Verkapselte zellen expremierend cytochrome p450 für die aktivierung einer medikamentenvorstufe |
-
1997
- 1997-03-27 DE DE69730595T patent/DE69730595D1/de not_active Expired - Lifetime
- 1997-03-27 CA CA002250173A patent/CA2250173A1/fr not_active Abandoned
- 1997-03-27 NZ NZ331765A patent/NZ331765A/en not_active IP Right Cessation
- 1997-03-27 HU HU9904116A patent/HU221349B1/hu not_active IP Right Cessation
- 1997-03-27 EP EP97919307A patent/EP0892852B1/fr not_active Expired - Lifetime
- 1997-03-27 RU RU98119459/14A patent/RU2185821C2/ru not_active IP Right Cessation
- 1997-03-27 AT AT97919307T patent/ATE309383T1/de not_active IP Right Cessation
- 1997-03-27 ES ES97919307T patent/ES2253775T3/es not_active Expired - Lifetime
- 1997-03-27 JP JP53405197A patent/JP4229982B2/ja not_active Expired - Lifetime
- 1997-03-27 PL PL97329071A patent/PL188323B1/pl not_active IP Right Cessation
- 1997-03-27 SI SI9730726T patent/SI0892852T1/sl unknown
- 1997-03-27 IL IL12579597A patent/IL125795A0/xx not_active IP Right Cessation
- 1997-03-27 DK DK97919307T patent/DK0892852T3/da active
- 1997-03-27 SK SK1323-98A patent/SK282744B6/sk not_active IP Right Cessation
- 1997-03-27 CZ CZ19983050A patent/CZ288074B6/cs not_active IP Right Cessation
- 1997-03-27 RU RU2002103465/15A patent/RU2223788C2/ru not_active IP Right Cessation
- 1997-03-27 AU AU23827/97A patent/AU713382B2/en not_active Expired
- 1997-03-27 WO PCT/EP1997/001585 patent/WO1997035994A2/fr active IP Right Grant
-
1998
- 1998-09-24 US US09/160,067 patent/US6893634B1/en not_active Expired - Lifetime
- 1998-09-28 NO NO19984540A patent/NO325392B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CZ305098A3 (cs) | 1999-01-13 |
JP4229982B2 (ja) | 2009-02-25 |
NO984540L (no) | 1998-09-28 |
DE69730595D1 (de) | 2004-10-14 |
HUP9904116A3 (en) | 2001-01-29 |
SK132398A3 (en) | 1999-04-13 |
SI0892852T1 (sl) | 2006-04-30 |
NO984540D0 (no) | 1998-09-28 |
HU221349B1 (en) | 2002-09-28 |
EP0892852A2 (fr) | 1999-01-27 |
US6893634B1 (en) | 2005-05-17 |
NZ331765A (en) | 2000-02-28 |
DK0892852T3 (da) | 2006-03-06 |
ES2253775T3 (es) | 2006-06-01 |
NO325392B1 (no) | 2008-04-21 |
PL329071A1 (en) | 1999-03-15 |
CZ288074B6 (cs) | 2001-04-11 |
ATE309383T1 (de) | 2005-11-15 |
IL125795A0 (en) | 1999-04-11 |
RU2223788C2 (ru) | 2004-02-20 |
WO1997035994A2 (fr) | 1997-10-02 |
WO1997035994A3 (fr) | 1997-11-20 |
AU713382B2 (en) | 1999-12-02 |
PL188323B1 (pl) | 2005-01-31 |
AU2382797A (en) | 1997-10-17 |
RU2185821C2 (ru) | 2002-07-27 |
HUP9904116A2 (hu) | 2000-04-28 |
JP2000509249A (ja) | 2000-07-25 |
CA2250173A1 (fr) | 1997-10-02 |
EP0892852B1 (fr) | 2005-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0702084B1 (fr) | Rétrovirus recombinants | |
Vile et al. | Retroviruses as vectors | |
US6117681A (en) | Pseudotyped retroviral particles | |
RU2185821C2 (ru) | Трансдуцирующие цитохром р450 ретровирусные векторы | |
US6776985B1 (en) | Encapsulated cells producing viral particles | |
US20140170709A1 (en) | Vector for gene therapy | |
EP0848757B1 (fr) | Utilisation de sequences regulatrices de la proteine acide du lactoserum ou du virus de la tumeur mammaire de la souris, aux fins d'expression ciblee de genes heterologues lies dans des cellules mammaires humaines et notamment dans des cellules du cancer mammaire humain | |
EP1115879B1 (fr) | Particules retrovirales protegees contre la destruction dont la mediation est assuree par le complement | |
EP0817860B1 (fr) | Particules retrovirales pseudotypees | |
US6540995B1 (en) | Encapsulated cells producing cytochrome P450 | |
Searle et al. | Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene | |
JPH11503916A (ja) | 高力価組換えレトロウイルス調製物による細胞の高効率エクスビボ形質導入 | |
US20040115800A1 (en) | Selectable marker for genetically engineered cells and tissues | |
Fassati et al. | Retroviral vectors | |
Burt et al. | Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes | |
Takebe et al. | MDR-1 8.3. 3 Cytidine Deaminase 8.3. 4 Aldehyde Dehydrogenase Class 1 Dihydrofolate Reductase | |
Miyao et al. | Investigations of Retroviral-Mediated Gene Therapy for Malignant Glioma: Transduction with HTK-Bearing Retroviruses Sensitizes Glioma Cells to Ganciclovir | |
Takebe et al. | Protection of Hematopoietic Progenitor Cells from Chemotherapy Toxicity by Transfer of Drug Resistance Genes | |
EP0859854A1 (fr) | Vecteurs retroviraux porteurs d'inhibiteurs 1 derives de cellules senescentes (sdi-1) ou de sequences de nucleotides de sdi-1 antisens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20110327 |